Product Overview

Rabeprazole Sodium IP 20 mg + Domperidone IP 10 mg is a combination pharmaceutical formulation developed for the management of acid-related gastrointestinal conditions accompanied by symptoms such as nausea, vomiting, and impaired gastric motility. The formulation combines effective acid suppression with gastrointestinal motility support, providing comprehensive symptomatic management.

Rabeprazole Sodium belongs to the proton pump inhibitor (PPI) class and works by reducing gastric acid production in the stomach. By inhibiting the proton pumps responsible for the final stage of acid secretion, it helps relieve acidity, heartburn, and acid reflux while supporting the healing of acid-related irritation.

Domperidone is a gastrointestinal prokinetic and antiemetic agent that helps improve gastric motility and supports the movement of food through the digestive tract. It also helps control nausea and vomiting associated with certain gastrointestinal conditions.

The combination of Rabeprazole Sodium and Domperidone provides a dual-action approach by addressing both excessive gastric acid production and gastrointestinal motility-related symptoms. It may be used as part of treatment plans for gastroesophageal reflux disease (GERD), dyspepsia, and other acid-related gastrointestinal conditions as prescribed by a qualified healthcare professional.

Manufactured under stringent WHO-GMP quality standards, the formulation is produced using advanced pharmaceutical processes and undergoes comprehensive quality testing to ensure safety, efficacy, purity, and pharmaceutical consistency.

Key Features

• Dual-action gastrointestinal formulation
• Helps reduce excessive gastric acid production
• Supports relief from acidity and heartburn
• Helps manage acid reflux symptoms
• Supports gastrointestinal motility
• Helps relieve nausea and vomiting
• Manufactured under strict WHO-GMP standards

Uses

• Gastroesophageal reflux disease (GERD) management
• Acidity and heartburn relief
• Acid reflux management
• Nausea and vomiting associated with gastrointestinal conditions
• Digestive discomfort and impaired gastric motility support

How It Works

Rabeprazole Sodium reduces gastric acid secretion by inhibiting proton pumps in the stomach. Domperidone improves gastrointestinal motility and helps control nausea and vomiting. Together, they provide comprehensive support for acid-related and motility-associated gastrointestinal symptoms.

Possible Side Effects

Common side effects may include:

• Headache
• Nausea
• Abdominal discomfort
• Diarrhea or constipation
• Dry mouth
• Dizziness
• Bloating

Patients should seek medical attention if severe allergic reactions, persistent abdominal pain, unusual heart rhythm, or other serious symptoms occur.

Precautions

• Use only under medical supervision
• Inform your doctor about liver, kidney, or heart conditions
• Inform your healthcare provider about all medications being taken
• Avoid prolonged self-medication
• Pregnant or breastfeeding women should consult a healthcare professional before use

Storage Instructions

Store in a cool, dry place away from direct sunlight, heat, and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured in WHO-GMP certified facilities, the formulation undergoes stringent quality control procedures and comprehensive testing to ensure safety, efficacy, purity, and dependable therapeutic performance. Each batch is evaluated according to strict pharmaceutical quality standards to maintain consistent quality and reliable patient outcomes.